Moore Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1K Hold
166,666
﹤0.01% 609
2025
Q4
$6.48K Hold
166,666
﹤0.01% 652
2025
Q3
$6.27K Hold
166,666
﹤0.01% 606
2025
Q2
$8.08K Hold
166,666
﹤0.01% 525
2025
Q1
$5.5K Hold
166,666
﹤0.01% 451
2024
Q4
$8.12K Hold
166,666
﹤0.01% 477
2024
Q3
$15.5K Hold
166,666
﹤0.01% 417
2024
Q2
$8.38K Hold
166,666
﹤0.01% 417
2024
Q1
$17.5K Hold
166,666
﹤0.01% 392
2023
Q4
$3.33K Hold
166,666
﹤0.01% 401
2023
Q3
$14.2K Hold
166,666
﹤0.01% 429
2023
Q2
$7K Hold
166,666
﹤0.01% 469
2023
Q1
$6.37K Hold
166,666
﹤0.01% 449
2022
Q4
$6.33K Hold
166,666
﹤0.01% 474
2022
Q3
$6K Hold
166,666
﹤0.01% 603
2022
Q2
$21K Hold
166,666
﹤0.01% 562
2022
Q1
$40K Hold
166,666
﹤0.01% 648
2021
Q4
$129K Hold
166,666
﹤0.01% 576
2021
Q3
$105K Hold
166,666
﹤0.01% 686
2021
Q2
$158K Buy
+166,666
New +$119K ﹤0.01% 685

Other funds holding COCHW

Moore Capital Management's COCHW Position: Q1 2026 in Review

Moore Capital Management held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 166,666 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Moore Capital Management first reported a position in COCHW in Q2 2021 and has held it in 20 quarters since. The position peaked at $158K in Q2 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Moore Capital Management held 166,666 shares of Envoy Medical Warrant worth $11.1K as of Q1 2026.
  • Moore Capital Management left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Moore Capital Management's portfolio in Q1 2026, its #609 holding.
  • Moore Capital Management first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 20 quarters since.
  • Moore Capital Management's Envoy Medical Warrant position peaked at $158K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.